deformity. The operative scar is soft and supple, and does not impede finger movement.
Based on clinical and histological evidence, it can be surmised that the extensive fibrous sheet was the result of fluid extravasation. Accumulation of extravasated fluid leads to fibrin deposition, which in turn ''glues'' the extensor tendons to the skin and bone restricting tendon gliding. [1] If not dispelled during the first few months, the fibrin converts into scar tissue with long-term loss of extensor tendon gliding and shortening of the dorsal joint capsules.
Injection technique, fragility of patient's veins, number of venepuncture attempts prior to establishing an operational IV line, and drug characteristics determine the likelihood of occurrence of extravasation. [2] Given the difficulties encountered in obtaining vascular access, frequent use of steel catheters, and catheter placement at sites with limited subcutaneous tissue (e.g. dorsum of hand or foot, scalp) [3] children and neonates are more prone to extravasations. We did not find any previous published report of extravasation-related peritendinous fibrosis of the hand in children; although occurrence of Volkmann's contracture following intravenous infusion on the leg in a child has been reported. [4] Our case differed from Volkmann's ischemic contracture as the involvement was diffuse and not related directly to compromise of arterial blood supply. Sir, Patients with pulmonary tuberculosis could benefit from the use of inhaled anti-tubercular drug (ATD) administration as it would deliver the drug directly at the site of infection. [1] It is also likely that lower doses would be required when the drugs are administered by inhalation. [2] A 'proof of concept' study was undertaken for comparing the concentrations of rifampicin (RIF), isoniazid (INH) and pyrazinamide (Z) in the epithelial lining fluid (ELF), alveolar macrophages (AM) and serum following low-dose administration via inhaled route and those following standard dose administration via oral route.
Following the approval of the Institutional Ethics Committee, healthy volunteers aged 20-50 years without prior history of tuberculosis and with baseline forced expiratory volume at 1 sec (FEV1) over 60% of predicted value for height, weight and gender were enrolled.
Informed consent was obtained prior to enrollment. The subjects were then randomized into two groups: Six subjects in Group A received capsule containing micro-particles of anti-tubercular drugs (ATD, INH 15 mg, RIF 30 mg and Z 75 mg with lactose as a carrier particle) using a dry powder inhaler. The particle size ranged from 1-10 µ with mass median aerodynamic diameter of 2.79 µ. The remaining six subjects in Group B received oral ATD (a tablet containing RIF 500 mg, INH 250 mg and Z 1250 mg) as a single dose at 8 h of fasting. As shown in Table 1 the mean concentrations of INH, Z and RIF achieved in ELF were 220, 15 and 83 times higher in the inhaled group than those in the oral ATD group. Similarly, the median AM intracellular concentrations of INH, Z and RIF As the first step, our study has demonstrated that inhaled ATDs attain appreciably higher levels in the ELF and AM as compared to orally administered drugs. Similarly, inhaled drug administration is associated with lower serum concentrations. Studies on multiple dose pharmacokinetics are required to further investigate our findings.
